You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 13 No. 3, September 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Is the Brain an "Immunologically Privileged Site"?

2. Studies in Induced Host Resistance to Transplantable Mouse Glioma Following Irradiation of Prior Implants

LABE C. SCHEINBERG, MD; ARNOLDO LEVY, MD; FREDKIC EDELMAN, MD

Arch Neurol. 1965;13(3):283-286.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE FAILURE of the brain to respond with a typical immune reaction when chailenged by intracerebral implantation of nonisologous tissue has led investigators to the concept of the brain as an "immunologically privileged site."1-4 We have previously investigated this concept by using intracerebral tumor homografts and intracerebral tumor isografts to sensitized animals and concluded that probably due to variable genetic relations and other factors not yet completely understood, the brain is only partially "immunologically privileged" in tumor transplantation experiments in various strains of inbred mice.5 In that study, using a transplantable glioma arising in C57BL/6J mice, it was shown that this tumor was rejected when transplanted to the subcutaneous tissues of six other strains of inbred mice. When transplanted to the brains of these same strains of mice, the tumor grew in 10 to 35% of those mouse strains, although it had been rejected in 100% of . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Saul R. Korey departments of neurology and neurological surgery, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. Career Investigator, Health Research Council of the City of New York (Dr. Scheinberg).


Footnotes

Submitted for publication April 5, 1965; accepted April 27.

Reprint requests to Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461 (Dr. Scheinberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.